Synergistic interaction between mazindol, an anorectic drug, and swim-stress on analgesic responses in the formalin test in mice

Neuroscience Letters

Volumn 355, Issue 1-2, 2004, Pages 13-16

  Vendruscolo, Leandro Franco ^a   Takahashi, Reinaldo Naoto ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Dopamine; Formalin test; Mazindol; NMDA receptor; Opioid; Swim stress

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANOREXIGENIC AGENT; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; FORMALDEHYDE; MAZINDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NARCOTIC ANTAGONIST; OPIATE; OPIATE PEPTIDE; OPIATE RECEPTOR; SODIUM CHLORIDE; SULPIRIDE;

ANALGESIA; ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAZIL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; DRUG USE; EXERCISE TEST; MALE; METABOLISM; MOUSE; MOUSE STRAIN; NERVE TRACT; NONHUMAN; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; STRESS; SWIMMING;

EID: 0347284304     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.10.030     Document Type: Article

References (20)

1. Altier N., Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65:1999;2269-2287.
2. Bittencourt A.L., Takahashi R.N. Mazindol and lidocaine are antinociceptives in the mouse formalin model: involvement of dopamine receptor. Eur. J. Pharmacol. 330:1997;109-113.
3. Carmody J., Cooper K. Swim stress reduces chronic pain in mice through an opioid mechanism. Neurosci. Lett. 74:1987;358-363.
4. Chait L.D., Uhlenhuth E.H., Johanson C.E. Reinforcing and subjective effects of several anorectics in normal human volunteers. J. Pharmacol. Exp. Ther. 242:1987;777-783.
5. Grisel J.E., Fleshner M., Watkins L.R., Maier S.F. Opioid and non-opioid interactions in two forms of stress-induced analgesia. Pharmacol. Biochem. Behav. 45:1993;161-172.
6. Hutson P.H., Bristow L.J., Thorn L., Tricklebank M.D. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103:1991;2037-2044.
7. Kirchgessner A.L., Bodnar R.J., Pasternak G.W. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model. Pharmacol. Biochem. Behav. 17:1982;1175-1179.
8. Kruk Z.L., Zarrindast M.R. Mazindol anorexia is mediated by activation of dopaminergic mechanisms. Br. J. Pharmacol. 58:1976;367-372.
9. Lewis J.W., Cannon J.T., Liebeskind J.C. Opioid and non-opioid mechanisms of stress analgesia. Science. 208:1980;623-625.
10. Lin Y., Morrow T.J., Kiritsy-Roy J.A., Terry L.C., Casey K.L. Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia. Brain Res. 479:1989;306-312.
11. Lufty K., Maidment N.T. Sensitization does not develop to cocaine-induced potentiation of the antinociceptive effect of morphine. Brain Res. Bull. 58:2002;7-12.
12. Mattei R., Carlini E.A. Mazindol: anorectic and behavioral effects in female rats. Arch. Int. Pharmacodyn. Ther. 330:1995;279-281.
13. Mogil J.S., Belknap J.K. Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacol. Biochem. Behav. 56:1997;61-66.
14. Pani L., Porcella A., Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol. Psychiatry. 5:2000;14-21.
15. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
16. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 37:2003;577-582.
17. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411:2001;483-487.
18. Vaccarino A.L., Marek P., Sternberg W., Liebeskind J.C. NMDA receptor antagonist MK-801 blocks non-opioid stress-induced analgesia in the formalin test. Pain. 50:1992;119-123.
19. Zambotti F., Carruba M.O., Barzaghi F., Vicentini L., Groppetti A., Mantegazza P. Behavioral effects of a new non-phenylethylamine anorexigenic agent. Eur. J. Pharmacol. 36:1976;405-412.
20. Zanin M., Takahashi R.N. Sex difference in sensitization to the locomotor effects of mazindol in rats. Brain Res. Bull. 34:1994;385-387.